diabetic retinopathy semaglutide and retinopathy: an OHDSI network study (Cai) Unveiling the Therapeutic Potential of

Two groups of symptoms were studied: gastrointestinal, including abdominal pain, nausea, and bobororhygma, as well as gynecological symptoms, including chronic pelvic pain, dysmenorrhea, and dyspareunia

The mechanism of the weight gain in these study mice was due to increased digestion of polysaccharides resulting in higher absorption and delivery of sugars to the liver

The SELECT trial found semaglutide cut the risk of cardiovascular disease by 20% among overweight and obese patients with heart disease

When the stomach empties more slowly, food and gas remain in the digestive tract for longer periods, creating sensations of fullness and discomfort

Energy level, appetite level, side effect severity